Últimas notícias Butantan Institute

Mosquito da dengue, Aedes aegypti
Health

Brazil’s dengue shot reaches nearly 80% efficacy

The inoculation was developed by Butantan Institute, in São Paulo. Tests show it protects against all four serotypes of the virus. The study should end in 2024.

Dose pediátrica na vacina do Instituto Butantan contra Covid-19 na Unidade Básica de Saúde - UBS Brás.
Health

Brazil resumes production of CoronaVac to immunize children

New doses are being produced by the Butantan Institute. The amount ordered by the Ministry of Health—1 million doses—is expected to be delivered in September.

Chegada de 59.800 doses da vacina CoronaVac (17.03.2021)
Foto: Breno Esaki/Agência Saúde DF
Health

Brazil drug authority receives data on CoronaVac for 3–5-year-olds

The sending of information was agreed at a meeting on May 25 between the institute and Anvisa, which will now proceed with the evaluation of the request.

Tubos de teste positivos varíola dos macacos
Health

Brazil monitors three suspected cases of monkeypox

In Santa Catarina, the suspected case is a 27-year-old woman, living in Dionísio Cerqueira. The patient had symptoms on May 24 and is awaiting the test results.

Coronavírus (COVID-19), Novo Coronavirus SARS-CoV-2
Health

Brazil confirms first case of Omicron subvariant

There is still not enough evidence to gauge such aspects as severity, transmission, and the effectiveness of existing vaccines, the institute stated.